Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Edmonton
- Most recent report
- 10-Q, filed Oct 30, 2026
- Incorporated
- N/A
- Filings on record
- 615 filings
- On EDGAR
- CIK 1600620
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 236
News 8 of 58
Prospectuses and Registrations 8 of 10
- S-8 Registration statement for an employee plan May 16, 2025
- S-8 Registration statement for an employee plan May 26, 2023
- S-3ASR Automatic shelf registration Nov 19, 2021
- S-8 Registration statement for an employee plan Jun 25, 2021
- S-8 Registration statement for an employee plan Feb 24, 2021
- S-8 Registration statement for an employee plan Jun 9, 2020
- S-8 Registration statement for an employee plan Sep 13, 2019
- S-8 Registration statement for an employee plan Jun 8, 2018
Proxies 8 of 23
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2025
- DEFA14A Extra proxy material Jun 4, 2024
- DEFA14A Extra proxy material Jun 4, 2024
- DEFA14A Extra proxy material May 3, 2024
- DEF 14A Proxy statement for a shareholder vote May 3, 2024
Ownership 8 of 250
- 4 Insider reported a trade Sep 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 26, 2026
- 4 Insider reported a trade Aug 25, 2026
- 144 Notice of a proposed sale of restricted stock Aug 21, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
Other 8 of 38
Everything here comes from Aurinia Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.